arrow
返回

PepSeA: Peptide Sequence Alignment and Visualization Tools to Enable Lead Optimization

delete2022-02-22
delete3
delete
OA
AI
J
Javier L. Baylon *
O
Oleg Ursu
A
Anja Muždalo
A
Anne Mai Wassermann
G
Gregory L. Adams
M
Martin Spale
P
Petr Mejzlík
A
Anna Gromek
V
Viktor Pisarenko
D
Dzianis Hancharyk
E
Esteban Jenkins
D
David Bednář
K
Kamila Clarová
M
Meir Glick
D
Danny A. Bitton *
DOI:10.1021/acs.jcim.1c01360delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Therapeutic peptides offer potential advantages over small molecules in terms of selectivity, affinity, and their ability to target undruggable proteins that are associated with a wide range of pathologies. Despite their importance, current molecular design capabilities that inform medicinal chemistry decisions on peptide programs are limited. More specifically, there are unmet needs for structure-activity relationship (SAR) analysis and visualization of linear, cyclic, and cross-linked peptides containing non natural motifs, which are widely used in drug discovery. To bridge this gap, we developed PepSeA (Peptide Sequence Alignment and Visualization), an open-source, freely available package of sequence-based tools (https://github.com/Merck/PepSeA). PepSeA enables multiple sequence alignment of non-natural amino acids and enhanced visualization with the hierarchical editing language for macromolecules (HELM). Via stepwise SAR analysis of a ChEMBL peptide data set, we demonstrate the utility of PepSeA to accelerate decision making in lead optimization campaigns in pharmaceutical setting. PepSeA represents an initial attempt to expand cheminformatics capabilities for therapeutic peptides and to enable rapid and more efficient design-make-test cycles.
Keyword:
CYCLIC-PEPTIDES
DRUG DISCOVERY
N-METHYLATION
IN-VITRO
PROTEIN
MAFFT
THERAPY
THERAPEUTICS
PARALLELIZATION
PERMEABILITY

期刊

Journal of Chemical Information and Modeling 封面图
Journal of Chemical Information and Modeling
IF:
5.3
论文数:
9.1K
被引数:
4.0W

机构

U
university of chemistry & technology, prague
学者数:
5.6K
论文数: 4.4K
被引数: 3
M
merck & company usa
学者数:
6.3K
论文数: 3.5K
被引数: 5
M
merck & company
学者数:
1.8W
论文数: 8.7K
被引数: 11
学者 查看更多机构
引用论文

引用论文

Infliximab and methotrexate in the treatment of rheumatoid arthritis英夫利昔单抗与甲氨蝶呤治疗类风湿关节炎
err2000-11-30
err2.8K
errOAAI
errLipsky, PE; van der Heijde, DMFM; St Clair, EW; Furst, DE; Breedveld, FC; Kalden, JR; Smolen, JS; Weisman, M; Emery, P; Feldmann, M; Harriman, GR; Maini, RN
err分享
err收藏
Use of 3D Properties to Characterize Beyond Rule-of-5 Property Space for Passive Permeation
err2012-03-20
err99
PREAI
errGuimaraes, Cristiano R. W.; Mathiowetz, Alan M.; Shalaeva, Marina; Goetz, Gilles; Liras, Spiros
err分享
err收藏
Interfering peptides targeting protein-protein interactions: the next generation of drugs?
err2018-02-01
err110
PREAI
errBruzzoni-Giovanelli, Heriberto; Alezra, Valerie; Wolff, Nicolas; Dong, Chang-Zhi; Tuffery, Pierre; Rebollo, Angelita
err分享
err收藏
ProbCons: Probabilistic consistency-based multiple sequence alignment
err2005-02-01
err952
errOAAI
errDo, CB; Mahabhashyam, MSP; Brudno, M; Batzoglou, S
err分享
err收藏
学者 查看更多内容